1Chalupka AN, Talmor D. The economics of sepsis. Crit Care Clin, 2012,28:57-76.
2American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992, 20:864-874.
4Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial. Crit Care Med, 2006, 34 : 1589-1596.
5Haaspera C,Kalmbacha M, Dikosb D, et al. Prognostic value of procalcitonin (PCT) and/or interleukin45 ( IL-6 ) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. Technology and Health Care, 2010, 18: 89-100.
6Yu ZB, Liu J, Qiu Y, et al. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: A meta-analysis. Scand J Infect Dis, 2010,42:723-733.
7Dahaba AA, Metzler H. Procalcitonin' s role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? Minerva Anestesiologica, 2009, 75:447-452.
8Shehabi Y, Seppeh I. Pro/con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Crit Care, 2008, 12: 211.
9Perren A, Cerutti B, Lepori M, et al. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia. Infection, 2008, 36: 163-166.
10Mtiller B, Peri G, Doni A, et al. High circulating levels of the IL- l type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol,2002,72:643-649.
